What Researchers Did
Researchers conducted a 3-month study to evaluate the effectiveness of intermittent hyperbaric oxygen in relieving drug-induced neuropathies in 22 patients with human immunodeficiency virus.
What They Found
Of the 20 patients who completed the series, 17 (85%) experienced significant improvement in their symptoms. Two patients had a demyelinating disorder that may have affected their outcome, while one patient showed no change.
What This Means for Canadian Patients
Canadian patients experiencing drug-induced HIV-associated neuropathy might potentially find relief from symptoms like numbness and tingling through intermittent hyperbaric oxygen therapy. This treatment could offer a valuable option for managing a challenging side effect of long-term antiretroviral medication use.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or participants.
Study Limitations
The study's small sample size of 20 completers and the absence of a control group limit the generalizability of its findings.